Get the Stockscreener App
74.19
2.76%
1.99
After Hours:
74.19
Henry Schein Inc stock is traded at $74.19, with a volume of 1.14M.
It is up +2.76% in the last 24 hours and up +3.20% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$72.20
Open:
$74.56
24h Volume:
1.14M
Relative Volume:
0.73
Market Cap:
$9.03B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
30.41
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
+7.03%
1M Performance:
+3.20%
6M Performance:
-0.75%
1Y Performance:
+6.00%
1-Day Range:
$74.15
$74.74
1-Week Range:
$68.90
$74.74
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
74.19 | 9.03B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
714.00 | 88.62B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
293.44 | 56.78B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
157.76 | 37.50B | 222.29B | 1.56B | 2.44B | 6.41 |
|
AHG
Akso Health Group Adr
|
1.92 | 793.65M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Acadia Healthcare, Henry Schein, The Pennant Group, Ziff Davis, and Atlassian Shares Are Soaring, What You Need To Know - Yahoo Finance
Henry Schein Inc. Stock Analysis and ForecastSky-high profits - Autocar Professional
Will CEO Succession Impact Henry Schein's (HSIC) Digital Transformation and Efficiency Goals? - simplywall.st
What drives Henry Schein Inc. stock priceSkyrocketing profit margins - Autocar Professional
What analysts say about Henry Schein Inc. stockOutstanding trading profits - jammulinksnews.com
Is Henry Schein Inc. a good long term investmentFree Daily Trading Room Entry - jammulinksnews.com
Henry Schein Announces Q2 2025 Earnings Release and Conference Call - AInvest
Henry Schein to Webcast Second Quarter 2025 Conference Call on Tuesday, August 5, 2025, at 8:00 a.m. ET - The Globe and Mail
Henry Schein's Quarterly Earnings Preview: What You Need to Know - MSN
What caused HSIC's 2024 earnings surprises? - AInvest
Henry Schein, Inc. (NASDAQ:HSIC) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock? - simplywall.st
Henry Schein announces CEO retirement - MSN
Insiders At Henry Schein Sold US$2.3m In Stock, Alluding To Potential Weakness - 富途牛牛
IntelePeer Joins Henry Schein One Academic Partner Program to Enhance Dental Education with Conversational AI - AInvest
IntelePeer Joins Henry Schein One Academic Partner Program - Yahoo Finance
Stanley M. Bergman to retire as Henry Schein CEO - Dental Tribune US
Henry Schein CEO Stanley Bergman Announces Retirement - The Globe and Mail
Henry Schein's Quarterly Earnings Preview: What You Need To Know - Barchart.com
Henry Schein CEO Stanley Bergman to retire - Newsday
Stanley Bergman To Retire as Henry Schein’s CEO at the End of The Year - Dentistry Today
Longtime Henry Schein CEO to Retire at End of 2025 - Modern Distribution Management
Stan Bergman to retire after 35 years as CEO of Henry Schein - Fierce Biotech
Henry Schein climbs; longtime CEO to retire - TradingView
Stanley M. Bergman To Retire as Henry Schein’s CEO - citybiz
Henry Schein falls after longtime CEO to retire - TradingView
Henry Schein announces CEO retirement (HSIC:NASDAQ) - Seeking Alpha
Henry Schein CEO Stanley Bergman to Retire at Yearend - MarketScreener
Henry Schein's Stanley Bergman to Retire as CEO at End of Year - MarketWatch
Stanley M. Bergman to Retire as Henry Schein’s Chief Executive Officer at the End of 2025 - The Globe and Mail
Why Henry Schein Inc. stock attracts strong analyst attentionBig Profit Small Risk Alerts - beatles.ru
Henry Schein Inc. stock underperforms Monday when compared to competitors - MSN
Henry Schein Trading Volume Surges 119.05% to Rank 412th Amid Stock Price Decline - AInvest
Henry Schein Stock Downgraded: Potential Loss of Major CustomerNews and Statistics - IndexBox
Why Henry Schein (HSIC) Shares Are Falling Today - Yahoo Finance
This Procter & Gamble Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Baird Downgrades Henry Schein to Neutral From Outperform, Adjusts Price Target to $72 From $82 - MarketScreener
Baird downgrades Henry Schein stock rating on potential customer loss - Investing.com India
Baird downgrades Henry Schein stock rating on potential customer loss By Investing.com - Investing.com UK
Medical distributor Henry Schein opens in Honolulu - Aloha State Daily
On Our Island: : ACLD, H2M, Team Schein and PRPLI - Long Island Business News
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Henry Schein (HSIC) Announces Completion of $250 Million Investment by KKR - Insider Monkey
Evercore ISI Adjusts Price Target on Henry Schein to $78 From $72 - MarketScreener
A Glimpse Into The Expert Outlook On Henry Schein Through 4 Analysts - Benzinga
11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds - Insider Monkey
Should You Retain Henry Schein Stock in Your Portfolio Right Now? - TradingView
Henry Schein's Strategic Acquisitions and Margin Gains: A Path to Sustainable Growth? - AInvest
Farmingdale State College Announces Henry Schein Cares Sensory Unit - MSN
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.52%
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):